Methotrexate, blood pressure and markers of arterial function in patients with rheumatoid arthritis: a repeated cross-sectional study

BACKGROUND: Methotrexate (MTX) treatment in rheumatoid arthritis (RA) has been associated with lower cardiovascular risk compared to other disease-modifying antirheumatic drugs (DMARDs). We sought to identify whether the MTX-associated cardioprotection involves changes in blood pressure (BP) and/or...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Musculoskelet Dis
Autors principals: Mangoni, Arduino A., Baghdadi, Leena R., Shanahan, E. Michael, Wiese, Michael D., Tommasi, Sara, Elliot, David, Woodman, Richard J.
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5600310/
https://ncbi.nlm.nih.gov/pubmed/28932292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X17719850
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars